Linzagolix Completed Phase 3 Trials for Endometriosis Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04335591Extension to Study on Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain (EDELWEISS 6)
NCT03992846Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain.